These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35640806)

  • 1. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
    Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
    Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel nanocrystal-based formulations of apremilast for improved topical delivery.
    Parmar PK; Bansal AK
    Drug Deliv Transl Res; 2021 Jun; 11(3):966-983. PubMed ID: 32588281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance.
    Shahine Y; El-Aal SAA; Reda AM; Sheta E; Atia NM; Abdallah OY; Ibrahim SSA
    Inflammopharmacology; 2023 Jun; 31(3):1341-1359. PubMed ID: 37010718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
    Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
    Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
    Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
    J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
    Jain A; Doppalapudi S; Domb AJ; Khan W
    J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 targeted indirubin nanocrystal-loaded hyaluronic acid hydrogel for the treatment of psoriasis.
    Li L; Liu C; Fu J; Wang Y; Yang D; Peng B; Liu X; Han X; Meng Y; Feng F; Hu X; Qi C; Wang Y; Zheng Y; Li P
    Int J Biol Macromol; 2023 Jul; 243():125239. PubMed ID: 37295696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation.
    Silva-Abreu M; Sosa L; Espinoza LC; Fábrega MJ; Rodríguez-Lagunas MJ; Mallandrich M; Calpena AC; Garduño-Ramírez ML; Rincón M
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and characterization of apremilast-loaded zinc oxide-mesoporous silica nanoparticles for psoriasis treatment.
    Rahangdale M; Solanki S; Patil P; Bhavsar D; Sawant K
    Ther Deliv; 2024; 15(6):449-462. PubMed ID: 38888579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Delivery of Hederacoside C-Loaded Nanoliposome Gel Alleviates Psoriasiform Skin Inflammation through the CCL17/Treg Axis.
    Chen Y; Liang CL; Liu H; Chen H; He Y; Lin J; He Z; Qiu F; Yang B; Lu C; Dai Z
    ACS Appl Mater Interfaces; 2024 Sep; 16(37):48969-48981. PubMed ID: 39233638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
    Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
    Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
    Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
    Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
    Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
    J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment.
    Sontakke A; Dighe S; Sharma R; Yadav V; Jain S
    Int J Pharm; 2024 Apr; 655():124026. PubMed ID: 38518872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects.
    Mousa AM; Alhumaydhi FA; Abdellatif AAH; Abdulmonem WA; AlKhowailed MS; Alsagaby SA; Al Rugaie O; Alnuqaydan AM; Aljohani ASM; Aljasir M; Alwashmi ASS; Soliman KEA; Yosof MYR; Elsheikh SY; Babiker AY; Alsuhaibani SA; Hegazy AMS; Seleem HS
    Cutan Ocul Toxicol; 2022 Mar; 41(1):33-42. PubMed ID: 34749565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-psoriatic potential of Solanum xanthocarpum stem in Imiquimod-induced psoriatic mice model.
    Parmar KM; Itankar PR; Joshi A; Prasad SK
    J Ethnopharmacol; 2017 Feb; 198():158-166. PubMed ID: 28052238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.
    Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y
    Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
    Palfreeman AC; McNamee KE; McCann FE
    Drug Des Devel Ther; 2013; 7():201-10. PubMed ID: 23569359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.